Intrinsic Value
Mereo BioPharma Group plc (MREO)
$2.65
+0.07 (+2.71%)
| Enterprise Value | 23,596,989,444.34 |
|---|---|
| Net Debt | -51.47 |
| Equity Value | 23,596,989,495.81 |
| Shares Outstanding | 659,453.92 |
| Equity Value Per Share | 35,782.62 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt